Arteriovenous Malformation

5

Review clinical trials related to Arteriovenous Malformation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils

The purpose of the Case-Specific Health Care Professional (HCP) Clinical Survey for Concerto Versa™ Detachable Coils, also known as the Concerto Versa HCP Clinical Assessment, is to collect early clinical data from HCPs to assess clinical safety and performance of the Concerto Versa™ Detachable Coils, when used in accordance with approved device labeling per the Instructions for Use (IFU). Data collected will generate clinical evidence to quantitatively assess clinical safety and device performance for the purpose of obtaining European Union Medical Device Regulation (EU MDR) approval.

Participants needed: 30
Trial details
Age: 22+Biological sex: AllType: ObservationalSponsor: Medtronic EndovascularUpdated: Jun 15, 2026
Eligibility criteria

Patient treated with Concerto Versa™ Detachable Coil is age ≥ 22 years at the ti... [+2]

Status: Not yet recruiting

The Clinical Application of Peripheral Embolization Coil Systems in Arteriovenous Embolization Within the Peripheral Vasculature

Evaluation of the Safety and Effectiveness of the Peripheral Embolization Coil System Manufactured by Suzhou Zhongtian Medical Instruments Co., Ltd. for the Treatment of Arteriovenous Embolization in the Peripheral Vasculature in a Real-World Setting

Participants needed: 139
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Suzhou Zenith Vascular Scitech Co., Ltd.Updated: Sep 5, 2025
Eligibility criteria

Aged 18 to 75 years (inclusive), regardless of gender; [+3]

The target vessel requires the concurrent use of other embolic materials (e.g.,... [+10]

Status: Recruiting

Clinical Study on Emergency Treatment of Cerebral Arteriovenous Malformation Bleeding

Cerebral arteriovenous malformation (AVM) is the leading cause of brain hemorrhage in young adults, characterized by sudden onset and rapid progression. The hybrid neurosurgical operating room is a diagnostic and therapeutic platform that integrates neurointervention and microneurosurgery, offering advantages such as one-stop rapid treatment and multimodal therapeutic approaches. This study aims to focus on patients with acute cerebral AVM-related hemorrhage through a multicenter, prospective, registry-based research approach. In the hybrid neurosurgical operating room, emergency cerebral angiography, neurointerventional embolization, microsurgical resection of the vascular malformation, or minimally invasive hematoma evacuation will be performed to explore the indications and advantages of the hybrid neurosurgical operating platform in emergency AVM hemorrhage management. The study seeks to establish standardized diagnostic and treatment protocols and operational workflows for emergency AVM hemorrhage management in the hybrid operating room. Through continuous quality improvement, the study aims to further reduce patient morbidity and mortality. This research will not only enhance the diagnostic and therapeutic level of cerebral AVM-related hemorrhage and improve patient outcomes but also effectively reduce medical costs and societal burdens.

Participants needed: 162
Trial details
Age: 18-70Biological sex: AllType: ObservationalSponsor: Beijing Tiantan HospitalUpdated: Aug 12, 2025Locations: 1
Eligibility criteria

Head CT confirmed cerebral hemorrhage, with indications for emergency surgery [+4]

Consciousness disorder due to serious underlying diseases [+2]

Status: Not yet recruiting

Diagnostic Imaging of Vascular Malformations Using MSOT and ULM

This clinical study evaluates the efficacy and accuracy of Multispectral Optoacoustic Tomography (MSOT) and Ultrasound Localization Microscopy (ULM) for imaging and diagnosing vascular malformations (venous, arteriovenous, lymphatic). The study aims to enhance diagnostic precision and improve treatment planning through advanced non-invasive imaging techniques.

Participants needed: 15
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital ErlangenUpdated: Jun 22, 2025Locations: 1
Eligibility criteria

Confirmed vascular malformations (arteriovenous, venous, or lymphatic). [+1]

No imaging for diagnostic confirmation has been performed or is planned. [+3]

Status: Recruiting

Proton Radiotherapy for Primary Central Nervous System Tumours in Adults

Open label, multi-centre prospective study. Adult patients with primary central nervous system tumours fulfilling the inclusion criteria according to the study protocol. The study consists of 2 sequential cohorts evaluated consecutively for the feasibility, safety and toxicity, as well as long-term survival data, when using spot scanning proton beam therapy.

Participants needed: 500
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Uppsala UniversityUpdated: Jun 13, 2016Locations: 6
Eligibility criteria

The patient must be at least 18 years old [+23]

Concomitant or previous malignancies. Exceptions are adequately treated basal ce... [+2]